May 4, 2023
Societal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023
Webcast Scheduled for Wednesday, May 10, 2023, at 4:30 p.m. EasternSAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE)…
Pharmaceuticals, Biotechnology and Life Sciences
Webcast Scheduled for Wednesday, May 10, 2023, at 4:30 p.m. EasternSAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE)…
SAN FRANCISCO, May 03, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc.,…
SEATTLE, May 03, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
DEER PARK, Ill., May 03, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on…
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq:BXRX) (the “Company”), a pharmaceutical company focused on innovative…
SEATTLE, May 03, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that…
SAN CARLOS, Calif., May 03, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…
NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming…
Preclinical data demonstrates that gamma-delta T cells have the ability to target other solid tumors such as ovarian cancer, supporting…
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive…